Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Capricor Therapeutics Inc...

    NASDAQ: CAPR · Real-Time Price · USD
    12.31
    0.53 (4.50%)
    At close: Jun 16, 2025, 3:59 PM
    12.50
    1.54%
    After-hours: Jun 16, 2025, 07:59 PM EDT

    Capricor Therapeutics Statistics

    Share Statistics

    Capricor Therapeutics has 45.71M shares outstanding. The number of shares has increased by 42.83% in one year.

    Shares Outstanding

    n/a
    		 45.71M

    Shares Change (YoY)

    n/a
    		 42.83%

    Shares Change (QoQ)

    n/a
    		 0.45%

    Owned by Institutions (%)

    n/a
    		 52.37%

    Shares Floating

    n/a
    		 40.15M

    Failed to Deliver (FTD) Shares

    n/a
    		 265,044

    FTD / Avg. Volume

    n/a
    		 12.2%

    Short Selling Information

    The latest short interest is 11.08M, so 24.24% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 11.08M

    Short % of Shares Out

    n/a
    		 24.24%

    Short % of Float

    n/a
    		 27.58%

    Short Ratio (days to cover)

    n/a
    		 5.1

    Valuation Ratios

    The PE ratio is -12.01 and the forward PE ratio is -22.22. Capricor Therapeutics's PEG ratio is -0.31.

    PE Ratio

    n/a
    		 -12.01

    Forward PE

    n/a
    		 -22.22

    PS Ratio

    n/a
    		 21.82

    Forward PS

    n/a
    		 1.3

    PB Ratio

    n/a
    		 3.34

    P/FCF Ratio

    n/a
    		 -11.7

    PEG Ratio

    n/a
    		 -0.31
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Capricor Therapeutics.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 7.77, with a Debt / Equity ratio of 0.01.

    Current Ratio

    n/a
    		 7.77

    Quick Ratio

    n/a
    		 7.77

    Debt / Equity

    n/a
    		 0.01

    Debt / EBITDA

    n/a
    		 -0.04

    Debt / FCF

    n/a
    		 -0.03

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $139,187.5

    Profits Per Employee

    n/a
    		 $-252,918.75

    Employee Count

    n/a
    		 160

    Asset Turnover

    n/a
    		 0.13

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by 148.19% in the last 52 weeks. The beta is 0.85, so Capricor Therapeutics's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.85

    52-Week Price Change

    n/a
    		 148.19%

    50-Day Moving Average

    n/a
    		 10.72

    200-Day Moving Average

    n/a
    		 13.28

    Relative Strength Index (RSI)

    n/a
    		 53.86

    Average Volume (20 Days)

    n/a
    		 2,172,023

    Income Statement

    In the last 12 months, Capricor Therapeutics had revenue of 22.27M and earned -40.47M in profits. Earnings per share was -1.15.

    Revenue

    n/a
    		 22.27M

    Gross Profit

    n/a
    		 20.84M

    Operating Income

    n/a
    		 -42.56M

    Net Income

    n/a
    		 -40.47M

    EBITDA

    n/a
    		 -41.14M

    EBIT

    n/a
    		 -42.56M

    Earnings Per Share (EPS)

    n/a
    		 -1.15
    Full Income Statement

    Balance Sheet

    The company has 11.29M in cash and 1.45M in debt, giving a net cash position of 9.84M.

    Cash & Cash Equivalents

    n/a
    		 11.29M

    Total Debt

    n/a
    		 1.45M

    Net Cash

    n/a
    		 9.84M

    Retained Earnings

    n/a
    		 -199.83M

    Total Assets

    n/a
    		 153.77M

    Working Capital

    n/a
    		 123.91M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -40M and capital expenditures -1.54M, giving a free cash flow of -41.53M.

    Operating Cash Flow

    n/a
    		 -40M

    Capital Expenditures

    n/a
    		 -1.54M

    Free Cash Flow

    n/a
    		 -41.53M

    FCF Per Share

    n/a
    		 -1.18
    Full Cash Flow Statement

    Margins

    Gross margin is 100%, with operating and profit margins of -191.13% and -181.71%.

    Gross Margin

    n/a
    		 100%

    Operating Margin

    n/a
    		 -191.13%

    Pretax Margin

    n/a
    		 -181.71%

    Profit Margin

    n/a
    		 -181.71%

    EBITDA Margin

    n/a
    		 -184.73%

    EBIT Margin

    n/a
    		 -191.13%

    FCF Margin

    n/a
    		 -186.51%

    Dividends & Yields

    CAPR does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for CAPR is $35, which is 184.3% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $35

    Price Target Difference

    n/a
    		 184.3%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 6
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Jun 5, 2019. It was a backward split with a ratio of 1:10.

    Last Split Date

    n/a
    		 Jun 5, 2019

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:10

    Scores

    Altman Z-Score

    n/a
    		 8.99

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist